Literature DB >> 8839027

Proper management of thromboembolic disease.

M A Spartalis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8839027      PMCID: PMC2608030     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


× No keyword cloud information.
  5 in total

1.  Prevention and production of thrombosis by alterations in electric environment.

Authors:  S I SCHWARTZ
Journal:  Surg Gynecol Obstet       Date:  1959-05

2.  Protein C and the development of skin necrosis during anticoagulant therapy.

Authors:  A W Broekmans; R M Bertina; E A Loeliger; V Hofmann; H G Klingemann
Journal:  Thromb Haemost       Date:  1983-06-28       Impact factor: 5.249

3.  [Thrombolytic action of heparin and a low molecular weight fraction].

Authors:  F Bousquet; C Doutremepuich; J L Gestreau; A Masse; F Toulemonde; E G Vairel
Journal:  Therapie       Date:  1985 Jan-Feb       Impact factor: 2.070

4.  Characteristics of fibrinolytic enzyme release from human monocytes.

Authors:  C G Ragsdale; W P Arend
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

5.  Effect of heparin on the fibrinolytic system.

Authors:  D Silver; J H Hall
Journal:  Surg Forum       Date:  1966
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.